| Cancer-related molecular mechanisms research | Lifetime | 141 | CN 55 | 99.32 |
| MicroRNA in disease regulation | Lifetime | 235 | CN 82 | 99.06 |
| Circular RNAs in diseases | Lifetime | 109 | CN 58 | 99.09 |
| RNA modifications and cancer | Lifetime | 594 | CN 66 | 98.82 |
| Cancer Cells and Metastasis | Lifetime | 503 | CN 25 | 97.87 |
| Immune cells in cancer | Lifetime | 433 | CN 49 | 97.64 |
| Ferroptosis and cancer prognosis | Lifetime | 368 | CN 181 | 95.97 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 244 | CN 32 | 95.08 |
| Cancer Mechanisms and Therapy | Lifetime | 389 | CN 58 | 96.06 |
| Flavonoids in Medical Research | Lifetime | 811 | CN 352 | 76.18 |
| Magnolia and Illicium research | Lifetime | 332 | CN 125 | 66.68 |
| Natural Compounds in Disease Treatment | Lifetime | 808 | CN 419 | 63.78 |
| Biological Stains and Phytochemicals | Lifetime | 819 | CN 150 | 45.07 |
| Cancer-related molecular mechanisms research | 2021-2025 | 12 | CN 8 | 99.84 |
| RNA modifications and cancer | 2021-2025 | 17 | CN 11 | 99.78 |
| Circular RNAs in diseases | 2021-2025 | 20 | CN 12 | 99.42 |
| MicroRNA in disease regulation | 2021-2025 | 42 | CN 24 | 99.35 |
| RNA Research and Splicing | 2021-2025 | 66 | CN 18 | 97.59 |
| Inflammatory Biomarkers in Disease Prognosis | 2021-2025 | 24 | CN 13 | 96.77 |
| Immune cells in cancer | 2021-2025 | 165 | CN 96 | 96.26 |
| interferon and immune responses | 2021-2025 | 90 | CN 47 | 95.01 |
| Ferroptosis and cancer prognosis | 2021-2025 | 216 | CN 171 | 96.42 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 68 | CN 10 | 93.69 |
| Cancer-related gene regulation | 2021-2025 | 196 | CN 127 | 91.37 |
| Immune Cell Function and Interaction | 2021-2025 | 922 | CN 200 | 91.43 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 502 | CN 184 | 89.14 |
| Extracellular vesicles in disease | 2021-2025 | 869 | CN 510 | 90.20 |
| Liver physiology and pathology | 2021-2025 | 215 | CN 92 | 85.87 |
| Cancer Cells and Metastasis | 2021-2025 | 810 | CN 172 | 85.40 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 519 | CN 99 | 83.23 |
| Phagocytosis and Immune Regulation | 2021-2025 | 317 | CN 127 | 79.10 |
| Inflammasome and immune disorders | 2021-2025 | 905 | CN 425 | 81.78 |
| S100 Proteins and Annexins | 2021-2025 | 334 | CN 51 | 75.84 |
| Nephrotoxicity and Medicinal Plants | 2021-2025 | 51 | CN 27 | 73.40 |
| Bone and Joint Diseases | 2021-2025 | 970 | CN 289 | 69.93 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 584 | CN 223 | 65.96 |
| Magnolia and Illicium research | 2021-2025 | 43 | CN 27 | 64.95 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 561 | CN 134 | 62.10 |
